
PS-2020a / part16
.pdf
|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1661 |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
|
367643001 |
M-3340A |
Cyst (morphologic abnormality) |
|
368479001 |
T-49217 |
Structure of superficial palmar venous arch (body structure) |
|
368481004 |
T-49218 |
Structure of deep palmar venous arch (body structure) |
|
368536000 |
T-18774 |
Structure of axillary fascia (body structure) |
|
368550005 |
T-C4752 |
Structure of paramammary lymph node (body structure) |
|
369790002 |
G-F616 |
Nottingham Combined Grade I: 3-5 points (finding) |
|
369791003 |
G-F617 |
Nottingham Combined Grade II: 6-7 points (finding) |
|
369792005 |
G-F618 |
Nottingham Combined Grade III: 8-9 points (finding) |
|
369991007 |
G-F749 |
N3: Metastasis to ipsilateral internal mammary lymph node(s) |
|
|
|
(finding) |
|
370129005 |
G-C036 |
Measurement method (attribute) |
|
370359005 |
F-38095 |
Electrocardiogram equivocal (finding) |
|
370367002 |
F-201B6 |
Exercise tolerance test equivocal (finding) |
|
370388006 |
F-00D5F |
Patient immunocompromised (finding) |
|
370512004 |
DD-661D2 |
Migration of implant or internal device (disorder) |
|
370951003 |
F-02087 |
Piggyback intraocular lens (finding) |
|
371013005 |
T-C430A |
Cardiophrenic angle lymph node (body structure) |
|
371036001 |
D7-76202 |
Postsurgical menopause (disorder) |
|
371195002 |
T-D0821 |
Bone structure of upper limb (body structure) |
|
371240000 |
G-A11A |
Red color (qualifier value) |
|
371244009 |
G-A11D |
Yellow color (qualifier value) |
|
371246006 |
G-A11E |
Green color (qualifier value) |
|
371251000 |
G-A12B |
White color (qualifier value) |
|
371252007 |
G-A12C |
Black color (qualifier value) |
|
371253002 |
G-A12D |
Gray color (qualifier value) |
|
371254008 |
G-A12E |
Brown color (qualifier value) |
|
371304004 |
T-0262C |
Skin structure of lower limb (body structure) |
|
371311000 |
T-02008 |
Skin structure of upper limb (body structure) |
|
371398005 |
T-D0801 |
Eye region structure (body structure) |
|
371422002 |
G-0338 |
History of substance abuse (situation) |
|
371439000 |
R-00254 |
Specimen type (observable entity) |
|
371469007 |
R-00258 |
Histologic grade (observable entity) |
|
371524004 |
R-42B89 |
Clinical report (record artifact) |
|
371564000 |
L-877FB |
Genus Rattus (organism) |
|
371565004 |
L-877FC |
Rattus norvegicus (organism) |
|
371572003 |
P0-006F1 |
Nuclear medicine procedure (procedure) |
|
371785003 |
R-002CC |
Ambu bag (physical object) |
|
371786002 |
R-00359 |
Pressure support ventilator (physical object) |
|
371787006 |
R-0038C |
Volume support ventilator (physical object) |
|
371788001 |
R-00310 |
Intracoronary Doppler guide wire (physical object) |
|
371789009 |
R-00311 |
Intracoronary pressure guide wire (physical object) |
|
- Standard -

Page 1662 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
371790000 |
R-00303 |
External counter-pulsation circulatory support device (physical |
|
|
object) |
371791001 |
R-00361 |
Radiofrequency ablation device (physical object) |
371794009 |
R-002F0 |
Cutting balloon angioplasty device (physical object) |
371795005 |
R-00312 |
Intravascular ultrasound device (physical object) |
371796006 |
R-002FD |
Directional coronary atherectomy device (physical object) |
371797002 |
R-0036F |
Saline thrombectomy device (physical object) |
371798007 |
R-00306 |
Fluid filled catheter (physical object) |
371799004 |
R-0030A |
Hall catheter (physical object) |
371800000 |
R-00379 |
Thermistor catheter (physical object) |
371801001 |
R-00304 |
Fiberoptic catheter (physical object) |
371802008 |
R-00383 |
Tip manometer (physical object) |
371803003 |
R-00334 |
Multi vessel coronary artery disease (disorder) |
371804009 |
R-00313 |
Left main coronary artery disease (disorder) |
371805005 |
R-00372 |
Significant coronary bypass graft disease (disorder) |
371807002 |
R-0038F |
Atypical angina (disorder) |
371808007 |
R-00368 |
Recurrentanginastatuspostpercutaneoustransluminalcoronary |
|
|
angioplasty (disorder) |
371809004 |
R-00366 |
Recurrentanginastatuspostcoronarystentplacement(disorder) |
371810009 |
R-00365 |
Recurrent angina status post coronary artery bypass graft |
|
|
(disorder) |
371811008 |
R-00369 |
Recurrent angina status post rotational atherectomy (disorder) |
371812001 |
R-00367 |
Recurrent angina status post directional coronary atherectomy |
|
|
(disorder) |
371813006 |
R-002C8 |
Acute mitral regurgitation from chordal rupture (disorder) |
371814000 |
R-002C7 |
Acute mitral regurgitation from chordal dysfunction (disorder) |
371815004 |
R-002C9 |
Acute mitral regurgitation from papillary muscle dysfunction |
|
|
(disorder) |
371816003 |
R-002CA |
Acutemitralregurgitationfrompapillarymusclerupture(disorder) |
371817007 |
R-002CB |
Acute ventricular septal rupture (disorder) |
371824008 |
R-00336 |
Myocardialischemiamanifestonstressteststatuspostmyocardial |
|
|
infarction (finding) |
371829003 |
R-00360 |
Pulmonary vein wedge pressure (observable entity) |
371835003 |
R-00308 |
Fractional flow reserve using intracoronary bolus (observable |
|
|
entity) |
371837006 |
R-0032D |
Mitral valve flow (observable entity) |
371838001 |
R-002E5 |
Cardiacoutputmeasurementbythermalbathmethod(procedure) |
371839009 |
R-00394 |
Derived flow, non-valve (observable entity) |
371840006 |
R-00385 |
Tricuspid valve flow (observable entity) |
371841005 |
R-00309 |
Fractional flow reserve using intravenous infusion (observable |
|
|
entity) |
371842003 |
R-00307 |
Fractional flow reserve (observable entity) |
371843008 |
R-002E7 |
Cardiacoutputmeasurementbythermalinlinemethod(procedure) |
371845001 |
R-002D3 |
Aortic valve flow (observable entity) |
- Standard -

|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1663 |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
|
371846000 |
R-0035D |
Pulmonary valve flow (observable entity) |
|
371847009 |
R-003A9 |
Tricuspid diastolic filling period (observable entity) |
|
371848004 |
R-0035C |
Pulmonary systolic ejection period (observable entity) |
|
371849007 |
R-0032C |
Mitral diastolic filling period (observable entity) |
|
371850007 |
R-002D2 |
Aortic systolic ejection period (observable entity) |
|
371851006 |
R-002D0 |
Angioplasty inflation pressure (observable entity) |
|
371852004 |
R-002CF |
Angioplasty inflation duration (observable entity) |
|
371853009 |
R-002F5 |
Derived period, non-valve (observable entity) |
|
371854003 |
R-0036C |
Rotational atherectomy speed (observable entity) |
|
371855002 |
R-00398 |
Hyperkinetic ventricular wall (finding) |
|
371856001 |
R-0033F |
Normal left heart hemodynamics (finding) |
|
371857005 |
R-00340 |
Normal left ventricular systolic function and wall motion (finding) |
|
371858000 |
R-0033E |
Normal left and right heart hemodynamics (finding) |
|
371859008 |
R-00342 |
Normal right heart hemodynamics (finding) |
|
371860003 |
R-0033D |
Normal coronary arteries (finding) |
|
371861004 |
R-00328 |
Mild intimal coronary irregularities without significant stenoses |
|
|
|
(finding) |
|
371862006 |
R-002F3 |
Depression of left ventricular systolic function (finding) |
|
371863001 |
R-0039F |
Perfusion finding (finding) |
|
371864007 |
R-00381 |
Thrombolysis in Myocardial Infarction grade 2: partial perfusion |
|
|
|
(finding) |
|
371865008 |
R-00382 |
ThrombolysisinMyocardialInfarctiongrade3:completeperfusion |
|
|
|
(finding) |
|
371866009 |
R-0037F |
ThrombolysisinMyocardialInfarctiongrade1:penetrationwithout |
|
|
|
perfusion (finding) |
|
371867000 |
R-0037E |
Thrombolysis in Myocardial Infarction grade 0: no perfusion |
|
|
|
(finding) |
|
371868005 |
R-00327 |
Mild hypokinesis of cardiac wall (finding) |
|
371869002 |
R-0032F |
Moderate hypokinesis of cardiac wall (finding) |
|
371870001 |
R-00370 |
Severe hypokinesis of cardiac wall (finding) |
|
371871002 |
R-00373 |
Single beats - numeric estimation technique (qualifier value) |
|
371872009 |
R-003A1 |
Post stenotic dilation (finding) |
|
371873004 |
R-00314 |
Luminal irregularities of coronary artery (finding) |
|
371874005 |
R-002E3 |
Cardiac catheterization gradient assessment phase (qualifier |
|
|
|
value) |
|
371875006 |
R-002FB |
Device withdrawn and / or removed (finding) |
|
371876007 |
R-002F7 |
Device at site of interest (finding) |
|
371877003 |
R-002F8 |
Device inserted into sheath (finding) |
|
371879000 |
R-002C4 |
Abnormally high (qualifier value) |
|
371880002 |
R-002C5 |
Abnormally low (qualifier value) |
|
371883000 |
R-00348 |
Outpatient procedure (procedure) |
|
371884006 |
R-00363 |
Range of measurement uncertainty (qualifier value) |
|
371885007 |
R-00362 |
Range of lower measurement uncertainty (qualifier value) |
- Standard -

Page 1664 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
371886008 |
R-00364 |
Range of upper measurement uncertainty (qualifier value) |
371887004 |
R-00338 |
Ninetieth percentile (qualifier value) |
371888009 |
R-00397 |
Fifth percentile (qualifier value) |
371889001 |
R-00337 |
Ninety-fifth percentile (qualifier value) |
371890005 |
R-00377 |
Tenth percentile (qualifier value) |
371892002 |
R-002F2 |
Delivered radiation dose (observable entity) |
371893007 |
R-0036B |
Restenotic lesion of coronary artery (finding) |
371894001 |
R-002E2 |
Bifurcation lesion of coronary artery (disorder) |
371895000 |
R-002EF |
Culprit lesion of coronary artery (finding) |
371896004 |
R-0037C |
Thrombolytic agent administered less than 3 hours before |
|
|
percutaneous coronary intervention (situation) |
371897008 |
R-0037A |
Thrombolytic agent administered between 3 and 6 hours before |
|
|
percutaneous coronary intervention (situation) |
371898003 |
R-0031B |
Medication administered before lab visit (situation) |
371899006 |
R-0031A |
Medication administered after lab visit (situation) |
371900001 |
R-00320 |
Medication not administered (situation) |
371901002 |
R-0031E |
Medicationadministeredlessthan72hoursbeforepercutaneous |
|
|
coronary intervention (situation) |
371902009 |
R-00399 |
Medicationadministeredafterpercutaneouscoronaryintervention |
|
|
(situation) |
371903004 |
R-0039A |
Medication administered during percutaneous coronary |
|
|
intervention (situation) |
371904005 |
R-0031F |
Medication administered prior to percutaneous coronary |
|
|
intervention (situation) |
371905006 |
R-0031C |
Medication administered during lab visit (situation) |
371906007 |
R-0037B |
Thrombolytic agent administered between 6 hours and 7 days |
|
|
before percutaneous coronary intervention (situation) |
371907003 |
R-0034A |
Oxygen administration by nasal cannula (procedure) |
371908008 |
R-00349 |
Oxygen administration by mask (procedure) |
371909000 |
R-00315 |
Magnet induced pacing (procedure) |
371910005 |
R-002D9 |
Atrioventricular sequential pacing (procedure) |
371911009 |
R-00318 |
Measurement of blood pressure using cuff method (procedure) |
371912002 |
R-002E1 |
Best value - numeric estimation technique (qualifier value) |
371913007 |
R-00355 |
Point source - numeric estimation technique (qualifier value) |
371914001 |
R-00353 |
Peak to peak - numeric estimation technique (qualifier value) |
371915000 |
R-002FC |
Diffuse disease of coronary artery (finding) |
371916004 |
R-0036A |
Representative - numeric estimation technique (qualifier value) |
371917008 |
R-00346 |
One standard deviation above mean (qualifier value) |
371918003 |
R-00388 |
Two standard deviations below mean (qualifier value) |
371919006 |
R-00347 |
One standard deviation below mean (qualifier value) |
371920000 |
R-00387 |
Two standard deviations above mean (qualifier value) |
371922008 |
R-00335 |
Multiple irregularities (qualifier value) |
371923003 |
R-00329 |
Mild to moderate (qualifier value) |
371924009 |
R-00330 |
Moderate to severe (qualifier value) |
- Standard -

|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1665 |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
|
371925005 |
R-00333 |
Most significant (qualifier value) |
|
371926006 |
R-0030C |
Highly significant (qualifier value) |
|
371928007 |
R-00345 |
Not significant (qualifier value) |
|
371931008 |
R-002E9 |
Combined diagnostic and therapeutic (procedure) |
|
371933006 |
R-0038B |
Upper limit of reference range (qualifier value) |
|
371934000 |
R-0039B |
Normality undetermined (qualifier value) |
|
371951007 |
R-003AA |
Vena anonyma (body structure) |
|
371952000 |
R-00376 |
Systemic arterial blood (substance) |
|
371953005 |
R-0035B |
Pulmonary artery blood (substance) |
|
371954004 |
R-0035E |
Pulmonary vein blood (substance) |
|
372073000 |
T-A010F |
Cerebral hemisphere structure (body structure) |
|
372074006 |
T-14122 |
Skeletal muscle structure of chest wall (body structure) |
|
372242005 |
T-AA092 |
Vitreous body part (body structure) |
|
372249001 |
R-00274 |
Tumor margin status (observable entity) |
|
372276001 |
R-00288 |
Nottingham Combined Grade (observable entity) |
|
372460008 |
G-D173 |
Intracardiac route (qualifier value) |
|
372463005 |
G-D17C |
Intracoronary route (qualifier value) |
|
372464004 |
G-D17D |
Intradermal route (qualifier value) |
|
372480009 |
C-00211 |
Macrolide (class of antibiotic, substance) (substance) |
|
372578001 |
F-616E7 |
Plasma expander (substance) |
|
372580007 |
F-616EB |
Bronchodilator (substance) |
|
372602008 |
F-616FE |
Metronidazole (substance) |
|
372614000 |
F-6171D |
Sedative (substance) |
|
372656001 |
F-6188F |
Opiate antagonist (substance) |
|
372664007 |
R-F2B1D |
Benzodiazepine (substance) |
|
372665008 |
F-61898 |
Non-steroidal anti-inflammatory agent (substance) |
|
372666009 |
F-61899 |
Skeletal muscle relaxant (substance) |
|
372677003 |
C-0023B |
Lincomycin (substance) |
|
372681003 |
F-618A5 |
Hemostatic agent (substance) |
|
372682005 |
F-618A6 |
Diphenhydramine (substance) |
|
372693007 |
F-618AE |
Class IV antiarrhythmic agent (substance) |
|
372695000 |
F-618AF |
Diuretic (substance) |
|
372700007 |
F-618B5 |
Nitrate-based vasodilating agent (substance) |
|
372703009 |
R-F2B1F |
Pentobarbital (substance) |
|
372722000 |
C-0024C |
Quinolone -class of antibiotic- (substance) |
|
372724004 |
F-61916 |
Succinylcholine (substance) |
|
372735009 |
C-0024E |
Vancomycin (substance) |
|
372784001 |
F-61955 |
Papaverine (substance) |
|
372787008 |
F-61957 |
Vasodilator (substance) |
|
372788003 |
C-00257 |
Sulfonamide -class of antibiotic- (substance) |
|
372790002 |
F-61959 |
Nondepolarizing agent (substance) |
|
372798009 |
R-F2B23 |
Barbiturate (substance) |
|
- Standard -

Page 1666 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
372806008 |
F-61969 |
Antihistamine (substance) |
372813008 |
F-6196E |
Antiarrhythmic agent (substance) |
372855004 |
F-61995 |
Class III antiarrhythmic agent (substance) |
372862008 |
F-6199A |
Anticoagulant (substance) |
372863003 |
F-6199B |
Phentolamine (substance) |
372872006 |
F-619A3 |
Bile acid sequestrant antilipemic agent (substance) |
372881000 |
F-619AA |
Vasoconstrictor (substance) |
372901004 |
R-F2B27 |
Butabarbital (substance) |
372906009 |
F-619EF |
Benzodiazepine antagonist (substance) |
373061006 |
R-002F6 |
Device applied to patient (finding) |
373062004 |
R-002FA |
Device used (finding) |
373066001 |
R-0038D |
Yes (qualifier value) |
373067005 |
R-00339 |
No (qualifier value) |
373068000 |
R-0038A |
Undetermined (qualifier value) |
373095005 |
R-002ED |
Coronary artery fistula to right atrium (disorder) |
373098007 |
R-00317 |
Mean - numeric estimation technique (qualifier value) |
373099004 |
R-00319 |
Median - numeric estimation technique (qualifier value) |
373100007 |
R-0032E |
Mode - numeric estimation technique (qualifier value) |
373102004 |
R-003AC |
Specimen from breast obtained by image guided core biopsy |
|
|
(specimen) |
373104003 |
R-002E6 |
Cardiac output measurement by thermal dye dilution method |
|
|
(procedure) |
373105002 |
R-002E4 |
Cardiac catheterization test/challenge phase (qualifier value) |
373108000 |
R-00357 |
Post percutaneous transluminal coronary angioplasty (finding) |
373110003 |
R-00300 |
Emergency procedure (procedure) |
373111004 |
R-0035A |
Procedure in coronary care unit (procedure) |
373112006 |
R-00302 |
Evaluation of murmur (procedure) |
373113001 |
R-0036E |
Routine procedure (procedure) |
373115008 |
R-0036D |
Routine - numeric estimation technique (qualifier value) |
373116009 |
D3-29096 |
Acute mitral regurgitation (disorder) |
373121007 |
R-00378 |
Test not done (qualifier value) |
373122000 |
R-00344 |
Normal ventricular wall motion (finding) |
373123005 |
R-0030D |
Hyperkinesis of region of cardiac wall (finding) |
373124004 |
R-00343 |
Normal size cardiac chamber (finding) |
373125003 |
R-002C6 |
Abnormally small cardiac chamber (finding) |
373126002 |
R-0032A |
Mildly enlarged cardiac chamber (finding) |
373127006 |
R-00331 |
Moderately enlarged cardiac chamber (finding) |
373128001 |
R-00316 |
Markedly enlarged cardiac chamber (finding) |
373129009 |
R-00341 |
Normal overall cardiac contractility (finding) |
373131000 |
R-0033B |
Non-restrictive ventricular septal defect (disorder) |
373132007 |
R-0033C |
Normal aortic root (finding) |
373133002 |
R-00301 |
Enlarged aortic root (finding) |
- Standard -

|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1667 |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
|
373134008 |
R-002CD |
Aneurysm of aortic root (finding) |
|
373135009 |
R-002D1 |
Annular abscess of aortic root (disorder) |
|
373136005 |
R-0030B |
Heart valve calcification (finding) |
|
373137001 |
R-0030F |
Immobile heart valve (finding) |
|
373138006 |
R-00389 |
Ulcerated lesion of coronary artery (finding) |
|
373140001 |
R-0033A |
No thrombus (situation) |
|
373141002 |
R-00356 |
Possible thrombus (situation) |
|
373142009 |
R-002F1 |
Definite thrombus (situation) |
|
373143004 |
R-00371 |
Severe thrombus (finding) |
|
373147003 |
R-00321 |
Administration of medication not done due to contraindication |
|
|
|
(situation) |
|
373148008 |
R-0037D |
Thrombolytic agent not administered because contraindicated |
|
|
|
(situation) |
|
373150000 |
R-003CA |
pNX:Regionallymphnodescannotbeassessed(e.g.,previously |
|
|
|
removed, or not removed for pathologic study) (breast) (finding) |
|
373151001 |
R-003CB |
pN0:Noregionallymphnodemetastasishistologically(i.e.,none |
|
|
|
greaterthan0.2mm),noadditionalexaminationforisolatedtumor |
|
|
|
cells (breast) (finding) |
|
373156006 |
R-003D0 |
pN1: Metastasis in 1 to 3 axillary lymph nodes, and/or in internal |
|
|
|
mammary nodes with microscopic disease detected by sentinel |
|
|
|
lymphnodedissectionbutnotclinicallyapparent(breast)(finding) |
|
373162001 |
R-003D6 |
pN2: Metastasis in 4 to 9 axillary lymph nodes, or in clinically |
|
|
|
apparentinternalmammarylymphnodesintheabsenceofaxillary |
|
|
|
lymph node metastasis (breast) (finding) |
|
373163006 |
R-003D7 |
pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least one |
|
|
|
tumor deposit greater than 2.0 mm) (breast) (finding) |
|
373164000 |
R-003D8 |
pN2b: Metastasis in clinically apparent internal mammary lymph |
|
|
|
nodes in the absence of axillary lymph node metastasis (breast) |
|
|
|
(finding) |
|
373165004 |
R-003D9 |
pN3a: Metastasis in 10 or more axillary lymph nodes (at least |
|
|
|
one tumor deposit greater than 2.0 mm), or metastasis to |
|
|
|
infraclavicular lymph nodes (breast) (finding) |
|
373166003 |
R-003DB |
pN3c: Metastasis in ipsilateral supraclavicular lymph nodes |
|
|
|
(breast) (finding) |
|
373167007 |
R-003DA |
pN3b: Tumor of breast with metastasis as per American Joint |
|
|
|
Committee on Cancer 6th Edition definition (breast) (finding) |
|
373169005 |
R-003DD |
pM0: No distant metastasis (breast) (finding) |
|
373170006 |
R-003DC |
pMX: Distant metastasis cannot be assessed (breast) (finding) |
|
373171005 |
R-003DE |
pM1: Distant metastasis (breast) (finding) |
|
373172003 |
R-003BA |
pT1: Tumor 2 cm or less in greatest dimension (breast) (finding) |
|
373173008 |
R-003B8 |
pTX: Primary tumor cannot be assessed (breast) (finding) |
|
373174002 |
R-003B9 |
pT0: No evidence of primary tumor (breast) (finding) |
|
373175001 |
R-003BB |
pTis: Carcinoma in situ (breast) (finding) |
|
373176000 |
R-003BC |
pTis: Ductal carcinoma in situ (breast) (finding) |
|
373177009 |
R-003BD |
pTis: Lobular carcinoma in situ (breast) (finding) |
|
373178004 |
R-003BE |
pTis:Pagetdiseasewithoutinvasivecarcinoma(breast)(finding) |
- Standard -

Page 1668 |
DICOM PS3.16 2020a - Content Mapping Resource |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
373179007 |
R-003BF |
pT1mic: Microinvasion 0.1 cm or less in greatest dimension |
|
|
(breast) (finding) |
373180005 |
R-003C0 |
pT1a: Tumor more than 0.1 cm but not more than 0.5 cm in |
|
|
greatest dimension (breast) (finding) |
373182002 |
R-003C3 |
pT2: Tumor more than 2 cm but not more than 5 cm in greatest |
|
|
dimension (breast) (finding) |
373183007 |
R-003C2 |
pT1c: Tumor more than 1 cm but not more than 2 cm in greatest |
|
|
dimension (breast) (finding) |
373184001 |
R-003C4 |
pT3: Tumor more than 5 cm in greatest dimension (breast) |
|
|
(finding) |
373185000 |
R-003C5 |
pT4: Tumor of any size with direct extension to chest wall or skin |
|
|
(breast) (finding) |
373186004 |
R-003C6 |
pT4a:Tumorofanysizewithextensiontochestwall,notincluding |
|
|
pectoralis muscle (breast) (finding) |
373187008 |
R-003C7 |
pT4b: Tumor of any size with edema (including peau d'orange) |
|
|
or ulceration of the skin of the breast or satellite skin nodules |
|
|
confined to the same breast (breast) (finding) |
373189006 |
R-003C8 |
pT4c: Tumor of any size with direct extension to chest wall (not |
|
|
includingpectoralismuscle)andedema(includingpeaud'orange) |
|
|
or ulceration of the skin of the breast or satellite skin nodules |
|
|
confined to the same breast (finding) |
373190002 |
R-003C9 |
pT4d: Inflammatory carcinoma (breast) (finding) |
373197004 |
R-00286 |
Polyp size, largest dimension (observable entity) |
373204007 |
R-003C1 |
pT1b:Tumormorethan0.5cmbutnotmorethan1cmingreatest |
|
|
dimension (breast) (finding) |
373206009 |
C-00216 |
Tetracycline (class of antibiotic, substance) (substance) |
373219008 |
F-617EF |
Antifungal (substance) |
373228009 |
F-617F7 |
H1 antihistamine (substance) |
373246003 |
F-6180B |
Anticholinergic agent (substance) |
373250005 |
F-6180F |
Depolarizing agent (substance) |
373254001 |
F-61814 |
beta-Blocking agent (substance) |
373260001 |
F-6181B |
Class I antiarrhythmic agent (substance) |
373262009 |
C-0021C |
Cephalosporin -class of antibiotic- (substance) |
373263004 |
F-6181D |
Cardiac adrenergic blocking agent (substance) |
373265006 |
F-6181F |
Analgesic (substance) |
373270004 |
C-0021D |
Penicillin -class of antibiotic- (substance) |
373278006 |
F-61861 |
Class II antiarrhythmic agent (substance) |
373288007 |
F-6186A |
General anesthetic (substance) |
373294004 |
F-6186F |
Low molecular weight heparin (substance) |
373297006 |
C-00231 |
Beta-lactam antibiotic (substance) |
373304005 |
F-61878 |
Calcium channel blocker (substance) |
373337007 |
F-618FE |
Methylphenidate (substance) |
373372005 |
F-02900 |
Histological grade finding (finding) |
373464007 |
F-6182F |
Ketamine (substance) |
373476007 |
F-6183C |
Midazolam (substance) |
- Standard -

|
DICOM PS3.16 2020a - Content Mapping Resource |
Page 1669 |
|
Concept ID (SCT) |
SNOMED ID (SRT) |
SNOMED Fully Specified Name |
|
373477003 |
F-6183D |
Local anesthetic (substance) |
|
373488009 |
F-61848 |
Methohexital (substance) |
|
373529000 |
F-618D7 |
Morphine (substance) |
|
373530005 |
F-618D8 |
Caloric agent (substance) |
|
373646006 |
F-61968 |
Giemsa stain (substance) |
|
373682001 |
F-619B7 |
Wright stain (substance) |
|
373738000 |
F-61639 |
Pancuronium (substance) |
|
373746004 |
F-61642 |
Coagulant (substance) |
|
373780001 |
F-6169A |
Mescaline (substance) |
|
373808002 |
R-41560 |
Curative - procedure intent (qualifier value) |
|
373825000 |
R-408F2 |
Staging - procedure intent (qualifier value) |
|
373846009 |
R-41561 |
Adjuvant - intent (qualifier value) |
|
373847000 |
R-41562 |
Neo-adjuvant - intent (qualifier value) |
|
373933003 |
R-424BE |
Acute onset (qualifier value) |
|
373945007 |
D3-90008 |
Pericardial effusion (disorder) |
|
384668003 |
F-02B9B |
Nottingham Combined Grade cannot be determined (finding) |
|
384692006 |
P5-C018A |
Intracavitary brachytherapy (procedure) |
|
385294005 |
T-61007 |
Salivary gland structure (body structure) |
|
385356007 |
R-00443 |
Tumor stage finding (finding) |
|
385380006 |
R-00461 |
Metastasis category finding (finding) |
|
385382003 |
R-00463 |
Node category finding (finding) |
|
385385001 |
R-00465 |
pT category finding (finding) |
|
385420005 |
F-61D54 |
Contrast media (substance) |
|
385474004 |
L-8B946 |
Bos taurus taurus subspecies domestic European cattle |
|
|
|
(organism) |
|
385484003 |
C-22830 |
Gram stain (substance) |
|
385524004 |
R-41F90 |
Lower limit of reference range (qualifier value) |
|
385651009 |
G-D30B |
In progress (qualifier value) |
|
385655000 |
G-D30F |
Suspended (qualifier value) |
|
385656004 |
G-D316 |
Ended (qualifier value) |
|
385673002 |
G-D217 |
Interval (qualifier value) |
|
386045008 |
T-0130A |
Hair structure (body structure) |
|
386053000 |
P0-009B4 |
Evaluation procedure (procedure) |
|
386103008 |
T-D048E |
Renal stone (substance) |
|
386124003 |
R-10041 |
Transseptal catheter (physical object) |
|
386125002 |
R-10042 |
Device crossed septum (finding) |
|
386131004 |
R-10043 |
Ablation power (observable entity) |
|
386132006 |
R-10044 |
Ablation frequency (observable entity) |
|
386134007 |
R-10045 |
Significant (qualifier value) |
|
386135008 |
R-10046 |
Significance undetermined (qualifier value) |
|
386136009 |
R-10047 |
Standard deviation (qualifier value) |
|
386137000 |
R-10048 |
Tortuous coronary artery (finding) |
|
- Standard -

Page 1670 |
DICOM PS3.16 2020a - Content Mapping Resource |
Concept ID (SCT) |
SNOMED ID (SRT) |
386138005 |
R-10049 |
386139002 |
R-10050 |
386140000 |
R-10051 |
386509000 |
P0-0409B |
386530009 |
F-02B35 |
386616007 |
F-201BD |
386661006 |
F-0A44A |
386693003 |
C-68165 |
386760001 |
P1-C0037 |
386761002 |
P1-C0038 |
386802000 |
P0-05CCA |
386839004 |
F-61AC5 |
386841003 |
F-61AC9 |
386842005 |
F-61ACA |
386910003 |
F-61B21 |
387056004 |
C-00286 |
387085005 |
F-61C76 |
387124009 |
F-61C97 |
387146001 |
F-61A26 |
387150008 |
F-61A28 |
387176008 |
F-61A3F |
387218008 |
F-61A66 |
387239001 |
F-61A76 |
387258005 |
F-61A7F |
387264003 |
R-F2B2C |
387286002 |
F-61A95 |
387341002 |
F-61AC4 |
387351001 |
F-61AFE |
387358007 |
F-61B05 |
387362001 |
F-B2135 |
387368002 |
F-61B0A |
387423006 |
F-61B48 |
387448009 |
F-61BB2 |
387480006 |
F-61BD0 |
387560008 |
F-61C65 |
387713003 |
P0-009C3 |
387736007 |
P1-48145 |
388168008 |
L-8BA18 |
388249000 |
L-8C3FB |
388254009 |
L-8C3FD |
388393002 |
L-8B1FB |
388445009 |
L-000A9 |
SNOMED Fully Specified Name
Stented coronary artery (finding)
Stenotic coronary artery (finding)
Ectatic coronary artery (finding)
Airway management (procedure)
Systemic vascular resistance (observable entity)
Shallow breathing (finding)
Fever (finding)
Ophthalmic phenylephrine (product)
Topical local anesthetic (procedure)
Local anesthesia (procedure)
Endometrial biopsy (procedure)
Remifentanil (substance)
Desflurane (substance)
Sevoflurane (substance)
Anastrozole (substance)
Linezolid (substance)
Cocaine (substance)
Thromboplastin (substance)
Droperidol (substance)
Bupivacaine (substance)
Enflurane (substance)
Etomidate (substance)
Gentian violet (substance)
Chlorpromazine (substance)
Diazepam (substance)
Methadone (substance)
Heroin (substance)
Halothane (substance)
Ephedrine (substance)
Epinephrine (substance)
Isoflurane (substance)
Propofol (substance)
Thiopental sodium (substance)
Lidocaine (substance)
Alfentanil (substance)
Surgical procedure (procedure)
Fine needle aspiration of breast (procedure)
Genus Bos (organism)
Genus Capra (organism)
Genus Ovis (organism)
Genus Sus (organism)
Genus Equus (organism)
- Standard -